Michael J Zachareas, MD

Inotek Pharmaceuticals is a privately held biotechnology company based in Lexington, MA, focused on the discovery and development of innovative drugs to address serious eye diseases such as glaucoma, ocular hypertension, age-related macular degeneration, and retinal neuropathies. Their lead program, trabodenoson INO-8875, is a highly selective adenosine mimetic that targets the A1 sub-receptor, offering a novel mechanism of action for the treatment of elevated intraocular pressure associated with glaucoma and ocular hypertension. With a deep pipeline of drug candidates, Inotek Pharmaceuticals aims to ameliorate inflammation, ischemia-reperfusion injury, and oxidative stress, which are key targets for eye disease treatments. Their experienced management team and successful track record in advancing clinical programs towards commercialization position the company to benefit patients and physicians in managing ocular diseases.Generated from the website

Dr. Bruce Goldberg is a renowned hypnotherapist specializing in past life regression and future life progression, having transitioned from a successful dental career to focus on his expanding international hypnotherapy practice. He is recognized for his engaging workshops, recorded webinars, and various self-hypnosis products, catering to those interested in exploring the transformative potential of hypnotherapy. As a media consultant and New Age metaphysical activist, Dr. Goldberg has appeared on numerous radio and television programs, sharing his insights into time travel and the metaphysical realms. His extensive body of work includes best-selling books and a variety of audio materials designed to guide individuals in their personal journeys through hypnosis. Generated from the website